Biologically, UBE2F knockdown in liver cancer cells inactivates mTORC1 to suppress cell growth, reduce cell size and induce autophagy, whereas liver-specific Ube2f deletion significantly inhibits liver steatosis and tumorigenesis induced by Pten loss. Here, PTEN is linked to liver cancer.